IDEXX Laboratories Q3 2022 Earnings Preview
IDEXX Laboratories (NASDAQ:IDXX) is scheduled to announce Q3 earnings results on Tuesday, November 1st, before market open.
The consensus EPS Estimate is $2.04 (+4.1% Y/Y) and the consensus Revenue Estimate is $830M (+2.4% Y/Y).
Over the last 1 year, IDXX has beaten EPS estimates 50% of the time and has beaten revenue estimates 75% of the time.
Over the last 3 months, EPS estimates have seen 0 upward revisions and 11 downward. Revenue estimates have seen 0 upward revisions  and 8 downward.